Phar­ma watch­dog calls out As­traZeneca, Glax­o­SmithK­line for breach­es on on­line con­duct

LinkedIn posts have land­ed two Big Phar­ma play­ers in the hot seat, ac­cord­ing to yes­ter­day’s run­down of com­pa­nies breach­ing the As­so­ci­a­tion of British Phar­ma­ceu­ti­cal In­dus­try’s (AP­BI) Code of Prac­tice.

The UK’s Pre­scrip­tion Med­i­cines Code of Prac­tice Au­thor­i­ty (PM­C­PA) has cit­ed both As­traZeneca and Al­ler­gan (which has since been ac­quired by Ab­b­Vie) for their so­cial me­dia pro­mo­tion, in­clud­ing posts made by se­nior staff mem­bers on the net­work­ing site LinkedIn. Bri­tan­nia Phar­ma­ceu­ti­cals, Glax­o­SmithK­line and Sanofi were al­so called out for their own ad­ver­tis­ing breach­es.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER